462 related articles for article (PubMed ID: 15016786)
21. Taking a basal follicle-stimulating hormone history is essential before initiating in vitro fertilization.
Roberts JE; Spandorfer S; Fasouliotis SJ; Kashyap S; Rosenwaks Z
Fertil Steril; 2005 Jan; 83(1):37-41. PubMed ID: 15652884
[TBL] [Abstract][Full Text] [Related]
22. Age-specific FSH levels as a tool for appropriate patient counselling in assisted reproduction.
Weghofer A; Margreiter M; Fauster Y; Schaetz T; Brandstetter A; Boehm D; Feichtinger W
Hum Reprod; 2005 Sep; 20(9):2448-52. PubMed ID: 15905294
[TBL] [Abstract][Full Text] [Related]
23. A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates.
Lahoud R; Al-Jefout M; Tyler J; Ryan J; Driscoll G
Hum Reprod; 2006 Oct; 21(10):2645-9. PubMed ID: 16785261
[TBL] [Abstract][Full Text] [Related]
24. Decreased ovarian reserve relates to pre-eclampsia in IVF/ICSI pregnancies.
Woldringh GH; Frunt MH; Kremer JA; Spaanderman ME
Hum Reprod; 2006 Nov; 21(11):2948-54. PubMed ID: 16951429
[TBL] [Abstract][Full Text] [Related]
25. In-vitro fertilisation treatment: factors affecting its results and outcome.
Qublan HS; Malkawi HY; Tahat YA; Areidah S; Nusair B; Khreisat BM; Al-Quraan G; Abu-Assaf A; Hadaddein MF; Abu-Jassar H
J Obstet Gynaecol; 2005 Oct; 25(7):689-93. PubMed ID: 16263545
[TBL] [Abstract][Full Text] [Related]
26. [Is the concentration of plasma FSH a criterion for refusal?].
Aubriot FX
J Gynecol Obstet Biol Reprod (Paris); 2005 Nov; 34(7 Pt 2):5S27-5S29. PubMed ID: 16340901
[TBL] [Abstract][Full Text] [Related]
27. Menstrual cycle length is an age-independent marker of female fertility: results from 6271 treatment cycles of in vitro fertilization.
Brodin T; Bergh T; Berglund L; Hadziosmanovic N; Holte J
Fertil Steril; 2008 Nov; 90(5):1656-61. PubMed ID: 18155201
[TBL] [Abstract][Full Text] [Related]
28. Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome.
Kailasam C; Keay SD; Wilson P; Ford WC; Jenkins JM
Hum Reprod; 2004 Jul; 19(7):1544-7. PubMed ID: 15142994
[TBL] [Abstract][Full Text] [Related]
29. [Gonadotrophin dose and ovarian response: relations to the clinical outcome of in vitro fertilization and embryo transfer].
Xiong XS; Chen SL; Sun L; Yin MN; Zhao EY; Song J
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):712-4. PubMed ID: 18504186
[TBL] [Abstract][Full Text] [Related]
30. Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized, placebo-controlled double-blind study.
Päkkilä M; Räsänen J; Heinonen S; Tinkanen H; Tuomivaara L; Mäkikallio K; Hippeläinen M; Tapanainen JS; Martikainen H
Hum Reprod; 2005 Aug; 20(8):2211-4. PubMed ID: 15817582
[TBL] [Abstract][Full Text] [Related]
31. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
[TBL] [Abstract][Full Text] [Related]
32. What is the best time to perform intracytoplasmic sperm injection/embryo transfer cycle after hysteroscopic surgery for an incomplete uterine septum?
Berkkanoglu M; Isikoglu M; Arici F; Ozgur K
Fertil Steril; 2008 Dec; 90(6):2112-5. PubMed ID: 18177864
[TBL] [Abstract][Full Text] [Related]
33. [Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?].
Grzegorczyk-Martin V; Khrouf M; Bringer-Deutsch S; Mayenga JM; Kulski O; Cohen-Bacrie P; Benaim JL; Belaisch-Allart J
Gynecol Obstet Fertil; 2012; 40(7-8):411-8. PubMed ID: 22521986
[TBL] [Abstract][Full Text] [Related]
34. The effect of duration of coasting and estradiol drop on the outcome of assisted reproduction: 13 years of experience in 1,068 coasted cycles to prevent ovarian hyperstimulation.
Abdalla H; Nicopoullos JD
Fertil Steril; 2010 Oct; 94(5):1757-63. PubMed ID: 19939366
[TBL] [Abstract][Full Text] [Related]
35. The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China.
Ji J; Liu Y; Tong XH; Luo L; Ma J; Chen Z
Hum Reprod; 2013 Oct; 28(10):2728-34. PubMed ID: 23887075
[TBL] [Abstract][Full Text] [Related]
36. [Oocyte and embryo quality and outcome of ICSI cycles in patients with polycystic ovary syndrome (PCOS) versus normo-ovulatory].
Kdous M; Chaker A; Zhioua A; Zhioua F
J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):133-43. PubMed ID: 19179017
[TBL] [Abstract][Full Text] [Related]
37. Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening.
Jain T; Soules MR; Collins JA
Fertil Steril; 2004 Jul; 82(1):180-5. PubMed ID: 15237009
[TBL] [Abstract][Full Text] [Related]
38. Outcome of ICSI in HIV-1-infected women.
Terriou P; Auquier P; Chabert-Orsini V; Chinchole JM; Cravello L; Giorgetti C; Halfon P; Salzmann J; Roulier R
Hum Reprod; 2005 Oct; 20(10):2838-43. PubMed ID: 15980007
[TBL] [Abstract][Full Text] [Related]
39. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
[TBL] [Abstract][Full Text] [Related]
40. The endocrine and follicular growth dynamics throughout the menstrual cycle in women with consistently or variably elevated early follicular phase FSH compared with controls.
de Koning CH; McDonnell J; Themmen AP; de Jong FH; Homburg R; Lambalk CB
Hum Reprod; 2008 Jun; 23(6):1416-23. PubMed ID: 18375407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
